LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Sean McCarthy will participate on a panel titled "Specialty Pharma Play: Are We Near the End?" at the Bio International Convention in Atlanta, GA
News | 05. 21. 2009
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.